Abstract
Herpesviruses are highly host specific and share a long synchronous evolution with their hosts. Only in rare cases, species barriers fall and allow animal to human or human to animal transmission. Among the zoonotic herpesviruses, Cercopithecine herpesvirus 1 is the most significant and can be transmitted from macaques to human. Conversely, Human herpesvirus 1 is capable of causing severe disease in primates. Besides those two examples, there are several herpesviruses with a certainly limited or only suspected ability to cross species barriers. Those include Saimiriine herpesvirus 2, Phocid herpesvirus 2, Equid herpesvirus 1, Epstein-Barr Virus, Marek’s disease virus, and pseudorabies virus. Concerning xenotransplantations, porcine gammaherpesviruses must be considered as a zoonotic threat.
Keywords: herpes B virus, herpes simplex virus, Marek’s disease virus, phocine herpesvirus
Introduction
The Herpesviridae are large DNA viruses of humans and vertebrates but members of this big virus family were also isolated from invertebrates such as mollusks (Fields, 2007). The family is part of the order Herpesvirales and is divided into three subfamilies, Alpha-, Beta- and Gammaherpesvirinae, with a growing number of identified species, which generally show a long-standing co-evolution of the respective viruses with their hosts. However, there are cases of a transfer of virus lineages between distantly related hosts (Ehlers et al., 2007; Ehlers et al., 2008a). Altogether, the phylogenetic data clearly indicate a very narrow host range and specificity of herpesviruses but show at the same time that there is a residual potential to cross host species barriers and to adapt to new hosts (Ehlers et al., 2008b), which raises the question of the present and possibly future zoonotic potential of herpesviruses.
The term zoonosis describes a phenomenon, which is characterized by the ability of a given disease agent to overcome species barriers between human and animals, mainly vertebrates. Zoonoses naturally occur more frequently among closely related host species, but transmissions of disease agents can also be found where barriers of transmission are inherently low or artificially lowered. Examples for such lowering of barriers of transmission are close contacts of humans to animals living in zoos or Safari Parks or situations where pets live in the same household with their owners. Lately, a specialized form of “close relationship” has become more and more important, namely the transplantation of xenogenic organs, particularly the potential use of organs from pigs in man.
Only rarely zoonotic infections are able to establish a sustained presence in the new host and often variations of the pathogen are necessary to adapt to the new host system (Parrish et al., 2008).
In this review, we will focus on the most important zoonotic infections caused by herpesviruses, which generally are rare because of the usual close and long-standing evolutionary relationship between viruses and their respective hosts.
Cercopithecine herpesvirus 1
Cercopithecine herpesvirus 1 (CeHV-1, Herpes B Virus, B virus) is by far the most important zoonotic threat to human health caused by a member of the herpesvirus family (Jainkittivong and Langlais, 1998b). The virus naturally causes a virtually asymptomatic infection in Asian macaques (Macaca mulatta and Macaca fascicularis) (Keeble et al., 1958; Davenport et al., 1994). The clinical picture in the natural host is comparable to Human herpesvirus 1 (HHV-1, herpes simplex virus type 1) infections in humans with mild mucocutaneous lesions upon primary infection, latency in sensory ganglia, and virus reactivation (Benson et al., 1989; Weigler, 1992b). Virus shedding mainly occurs via bodily fluids, like saliva or other contaminated excretions upon primary infection or reactivation (Weigler et al., 1993b). The seroprevalence of CeHV-1 varies between different studies from 5.3% in urban performance monkeys in Indonesia up to 97% of >2.5 year old monkeys housed at the California Regional Primate Research Center. Generally, the seroprevalence is comparable to that of HHV-1 in humans such that it is lower in younger animals and increases as a function of age (Shah and Morrison, 1969; Weigler et al., 1990; Kessler and Hilliard, 1990; Weigler et al., 1993a; Schillaci et al., 2005; Sariol et al., 2006; Lee et al., 2007). Approximately 40% of seropositive macaques were found to be PCR positive for CeHV-1 sequences in trigeminal ganglia (Oya et al., 2008).
While causing mostly very mild or asymptomatic infections in its natural host, CeHV-1 can be fatal in humans. The main route of transmission is exposure to saliva from infected animals by bites and scratches, but needle-stick injuries and even airborne infections were also reported (Palmer, 1987; Holmes et al., 1990; Artenstein et al., 1991; Weigler, 1992a). In addition, one case of human-to-human transmission of CeHV-1 is documented (Centers for Disease Control (CDC), 1989). Although all known CeHV-1 infections are related to animals held in captivity for biomedical research, infections of humans at places that will allow close contact with macaques are possible and remain a potentially serious threat to human health (Cohen et al., 2002c). For that reason, CeHV-1 seropositive animals are sometimes culled, as was done e.g. at Woburn Safari Park (U.K.) (CDR, 2000).
The onset of symptoms of CeHV-1 infections and the progress of the disease often depend on the route and the dose of infection. Primary vesicular lesions are mostly found at the site of exposure. Also, itching, pain, numbness and lymphadenopathy are occasionally seen proximal to the site of infection. Usually those primary symptoms are followed by a general flu-like illness. In the majority of the cases in which antiviral treatment was not initiated, the patients developed encephalitis resulting in severe neurological disorders combined with high mortality reaching up to 80% (Jainkittivong and Langlais, 1998a; Cohen et al., 2002b; Huff and Barry, 2003). There is some speculation about asymptomatic human CeHV-1 infections, but since no asymptomatic, seropositive contact individuals could be identified so far, those cases might only occur rarely or not at all (Freifeld et al., 1995).
Other primate herpesviruses
Other primate herpesviruses, like Cercopithecine herpesvirus 2 (simian agent 8) or Cercopithecine herpesvirus 16 (baboon herpesvirus 2) have also been discussed to have a zoonotic impact; however, neither of the viruses could unambiguously be linked with any cases of human disease (Kalter and Heberling, 1990; Borchers and Ludwig, 1991; Black and Eberle, 1997; Rogers et al., 2006; Ritchey et al., 2006). Yet another herpesvirus that is discussed as a zoonotic agent is Saimiriine herpesvirus 2 (SaHV-2, herpesvirus saimiri). Its natural hosts are squirrel monkeys, which are usually infected within the first two years of life. The infection in the monkeys is completely asymptomatic and the virus persists in its host for life (Melendez et al., 1968). Upon experimental infection of New World primates, however, T-cell lymphomas can be induced (Melendez et al., 1969b; Wright et al., 1976). In cell culture, human T-lymphocytes can readily be transformed with SaHV-2 subgroup C (Biesinger et al., 1992). Although no human infections with SaHV-2 were reported so far, this member of the Gammaherpesvirinae, genus Rhadinovirus, presents a clear potential threat for zoonotic infections and raises the bar for the use of SaHV-2 for gene therapy or oncolysis, which is propagated by some investigators due to its lymphotropism that is a desired characteristic of such a tool (Griffiths et al., 2006; Vaha-Koskela et al., 2007). Before SaHV-2 could be used as a gene delivery vehicle, however, extensive testing as to vector safety would have to be completed, especially given the relatively close relationship with Human herpesvirus 8, the causative agent of Kaposi sarcoma.
Herpesviruses associated with zoonotic potential
Certainly, herpesviruses that can readily infect human cells in cell culture theoretically represent zoonotic threats. Examples for this category of herpesviruses are members of the Alphaherpesvirinae such as Suid herpesvirus 1 (SuHV-1, pseudorabies virus) or equid herpesvirus 1 (EHV-1). The latter was shown to be able to infect a wide spectrum of cells coming from various host species and tissues in vitro, among them human epithelial cells and peripheral blood mononuclear cells. In addition, productive intranasal infection with EHV-1 of other species such as the mouse or Syrian hamster could be shown, thereby demonstrating the potential of EHV-1 to cross species barriers. Since there are no seropositive results from human routinely working with EHV-1 and no human infections were reported so far, the threat seems to largely be theoretical in nature (Trapp et al., 2005).
SuHV-1 is the causative agent for Aujeszky’s disease in swine and can also break species barriers and establish infections e.g. in sheep, dogs, cattle, panther or mink. Infections of species other than swine invariably results in severe neurological symptoms and death of the affected animals (Kluge et al., 1992; Glass et al., 1994; Marcaccini et al., 2008). Despite an anecdotic report about three cases of PRV infections in man, humans and primates, for unknown reasons, seem to be refractory to infection with this virus. HHV-1, HHV-2 and SuHV-1 were shown to use the same set of cellular receptors for entry into target cells. Consequently, a post-entry restriction of virus growth is likely but has not been investigated in any detail (Mravak et al., 1987; Kluge et al., 1992).
Yet another alphaherpesvirus, Gallid herpesvirus 2 (GaHV-2, Marek’s disease virus), was claimed to be involved in human infections. First, a connection was postulated in some reports between GaHV-2 infection and multiple sclerosis (McStreet et al., 1992). Another study reported that human serum samples apparently tested GaHV-2-positive by PCR (Laurent et al., 2001). The results, however, could not be reproduced by other research groups and must therefore be deemed inconclusive (Hennig et al., 1998; Hennig et al., 2003). At least, there is no formal proof or even likelihood of an infection of humans with this avian herpesvirus that is capable of infecting host species other than the chicken, namely the turkey and the quail.
Another herpesvirus with a zoonotic potential is a seal gammaherpesvirus, Phocid herpesvirus 2 (PhHV-2). Although gammaherpesviruses usually are narrowly host restricted, PhHV-2 isolates are able to infect a wide variety of cells from different species in vitro, also including primate and human cell lines. In addition, experimental infections of mice and even monkeys are possible and virus replication could be confirmed in the upper respiratory tract and in PBMCs (Martina et al., 2007).
Lowered barriers of transmission - xenotransplantations
The availability of a sufficient number of suitable donor organs is a decisive bottleneck for human transplantation medicine. For decades, ongoing research has tried to overcome that problem by using xenogenic organs and for many reasons the domestic pig is the species of choice for producing organs for xenotransplantation (Calne, 1966; Deodhar, 1986; Schuurman and Pierson, III, 2008). One of the big concerns for the completion of this dream, besides all the immunological problems that would result in immediate rejection of the transplant, is the transmission of viruses from the donor animal to the recipient by infected or contaminated organs (Isacson and Breakefield, 1997; Fishman and Patience, 2004). Not only would the barrier of transmission be reduced dramatically in patients receiving such an organ from a different species. All organ recipients, regardless of the source of the organ, have to receive immunosuppressive therapy post transplantation to minimize the risk of transplant rejection. Such immunosuppressive therapy, unfortunately, also drastically reduces the ability of the host immune system to restrict persistent or latent viruses present in the transplant. It is therefore well known that e.g. human cytomegalovirus present in the recipient or “incoming” with the organ represent a serious threat in transplantation medicine because immunosuppressive therapy can cause reactivation of the virus (Slifkin et al., 2004). Among the porcine viruses potentially causing problems after xenotransplantation are retro-but also gammaherpesviruses, which potentially pose such a threat. Recently, it was shown that porcine lymphotropic herpesvirus 1 and its close human relatives, Human herpesvirus 8 (HHV-4, Epstein-Barr Virus and Human herpesvirus 8, are capable of transactivating each other. Since co-infection of recipients with HHV-4 and the porcine virus would be highly likely, a double infection of one and the same cells with both gammaherpesviruses cannot be excluded. Consequently, such co-infections, especially under immunosuppressive therapy, may result in reactivation of HHV-4 and present a clear threat to the sustained health of the individual receiving a porcine transplant. It is also conceivable that the porcine viruses adapt to and establish a foothold in humans, thereby causing bona fide zoonotic infection. Therefore, in the case of xenotransplants, one will have to weigh the health of the individual (and right thereto) to the potential health threat to the general population, which presents quite a substantial ethical problem (Santoni et al., 2006).
Human to animal transmission
Besides infections of man by animal viruses, zoonotic infections of animals with human herpesviruses have also been demonstrated. There is a report of an HHV-1 infection in a group of marmosets resulting in a mortality of 100% (Matz-Rensing et al., 2003). In addition, infection with HHV-1 of other New World primates was reported, also resulting in fatal disease (Melendez et al., 1969a; McClure and Keeling, 1971). For as yet unknown reasons, Old World primates appear to be less susceptible to HHV-1 and infection results in clinical signs comparable to those after infection of humans (Smith et al., 1969; Emmons and Lennette, 1970; McClure et al., 1980; Heldstab et al., 1981; Ramsay et al., 1982).
There is also evidence for potential HHV-4 infection in dogs. Not only can rat and canine cell lines stably be infected with HHV-4, but HHV-4 or and HHV-4 -like infection could be detected in pet dogs serologically, by PCR, nucleotide sequencing and in situ hybridization (Yang et al., 2000; Chiou et al., 2005). Taken together, one has to conclude from the studies summarized above that there either is transmission of HHV-4 to dogs or there are canine gammaherpesviruses that are closely related to HHV-4.
Concluding Remarks
Overall, herpesviruses have a long-standing, most near-commensal relationship with the species they have co-evolved with. There are only two examples where there is clear evidence for herpesviruses causing zoonoses. One of the viruses is herpes CeHV-1, which presents a clear threat for people working or getting in close contact with macaques. The second herpesvirus with clear zoonotic potential is the the closely related alphaherpesvirus HHV-1, which is capable to establish productive and lethal infection in primates. All the other examples of putative and suspected herpesvirus zoonoses are of theoretical or sometimes even anecdotal nature. Taken together, herpesviruses are highly species-specific and present an almost negligible zoonotic threat. However, as is the case for certainly almost all infectious agents, the risk for a zoonotic infection is increased when closer contacts to infected hosts are established and barriers of transmission are lowered. These latter scenarios are certainly becoming ever more important with the advent of xenotransplantation and the adaptation of “exotic” companion animals. Therefore, an increased vigilance towards herpesvirus infections of man transmitted by diseases is imperative.
Acknowledgments
Research in the authors’ laboratories is supported by the National Cancer Institute of the National Health Institute, the United States Department of Agriculture, the Deutsche Forschungsgemeinschaft and Morris Animal Foundation. .
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Reference List
- Artenstein AW, Hicks CB, Goodwin BS, Jr, Hilliard JK. Human infection with B virus following a needlestick injury. Rev Infect Dis. 1991;13:288–291. doi: 10.1093/clinids/13.2.288. [DOI] [PubMed] [Google Scholar]
- Benson PM, Malane SL, Banks R, Hicks CB, Hilliard J. B virus (Herpesvirus simiae) and human infection. Arch Dermatol. 1989;125:1247–1248. [PubMed] [Google Scholar]
- Biesinger B, Muller-Fleckenstein I, Simmer B, Lang G, Wittmann S, Platzer E, Desrosiers RC, Fleckenstein B. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci U S A. 1992;89:3116–3119. doi: 10.1073/pnas.89.7.3116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Black DH, Eberle R. Detection and differentiation of primate alpha-herpesviruses by PCR. J Vet Diagn Invest. 1997;9:225–231. doi: 10.1177/104063879700900301. [DOI] [PubMed] [Google Scholar]
- Borchers K, Ludwig H. Simian agent 8--a herpes simplex-like monkey virus. Comp Immunol Microbiol Infect Dis. 1991;14:125–132. doi: 10.1016/0147-9571(91)90126-x. [DOI] [PubMed] [Google Scholar]
- Calne RY. Homo- and heterotransplantation. Curr Probl Surg. 1966:3–56. doi: 10.1016/s0011-3840(66)80016-3. [DOI] [PubMed] [Google Scholar]
- CDR. Monkeys with herpes B virus culled at a safari park. Commun Dis Rep CDR Wkly 10. 2000;99:102. [PubMed] [Google Scholar]
- Centers for Disease Control (CDC) B-Virus Infections in Humans - Michigan. Archives of Dermatology. 1989;125:1183. [Google Scholar]
- Chiou SH, Chow KC, Yang CH, Chiang SF, Lin CH. Discovery of Epstein-Barr virus (EBV)-encoded RNA signal and EBV nuclear antigen leader protein DNA sequence in pet dogs. J Gen Virol. 2005;86:899–905. doi: 10.1099/vir.0.80792-0. [DOI] [PubMed] [Google Scholar]
- Cohen JI, Davenport DS, Stewart JA, Deitchman S, Hilliard JK, Chapman LE. Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1) Clin Infect Dis. 2002a;35:1191–1203. doi: 10.1086/344754. [DOI] [PubMed] [Google Scholar]
- Cohen JI, Davenport DS, Stewart JA, Deitchman S, Hilliard JK, Chapman LE. Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1) Clin Infect Dis. 2002b;35:1191–1203. doi: 10.1086/344754. [DOI] [PubMed] [Google Scholar]
- Cohen JI, Davenport DS, Stewart JA, Deitchman S, Hilliard JK, Chapman LE. Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1) Clin Infect Dis. 2002c;35:1191–1203. doi: 10.1086/344754. [DOI] [PubMed] [Google Scholar]
- Davenport DS, Johnson DR, Holmes GP, Jewett DA, Ross SC, Hilliard JK. Diagnosis and management of human B virus (Herpesvirus simiae) infections in Michigan. Clin Infect Dis. 1994;19:33–41. doi: 10.1093/clinids/19.1.33. [DOI] [PubMed] [Google Scholar]
- Deodhar SD. Review of xenografts in organ transplantation. Transplant Proc. 1986;18:83–87. [PubMed] [Google Scholar]
- Ehlers B, Dural G, Yasmum N, Lembo T, de TB, Ryser-Degiorgis MP, Ulrich RG, McGeoch DJ. Novel mammalian herpesviruses and lineages within the Gammaherpesvirinae: cospeciation and interspecies transfer. J Virol. 2008b;82:3509–3516. doi: 10.1128/JVI.02646-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ehlers B, Dural G, Yasmum N, Lembo T, de TB, Ryser-Degiorgis MP, Ulrich RG, McGeoch DJ. Novel mammalian herpesviruses and lineages within the Gammaherpesvirinae: cospeciation and interspecies transfer. J Virol. 2008a;82:3509–3516. doi: 10.1128/JVI.02646-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ehlers B, Kuchler J, Yasmum N, Dural G, Voigt S, Schmidt-Chanasit J, Jakel T, Matuschka FR, Richter D, Essbauer S, Hughes DJ, Summers C, Bennett M, Stewart JP, Ulrich RG. Identification of novel rodent herpesviruses, including the first gammaherpesvirus of Mus musculus. J Virol. 2007;81:8091–8100. doi: 10.1128/JVI.00255-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Emmons RW, Lennette EH. Natural herpesvirus hominis infection of a gibbon (Hylobates lar) Arch Gesamte Virusforsch. 1970;31:215–218. doi: 10.1007/BF01253755. [DOI] [PubMed] [Google Scholar]
- Fields BN. Virology. Lippincott Williams & Wilkins; Philadelphia, USA: 2007. [Google Scholar]
- Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant. 2004;4:1383–1390. doi: 10.1111/j.1600-6143.2004.00542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Freifeld AG, Hilliard J, Southers J, Murray M, Savarese B, Schmitt JM, Straus SE. A controlled seroprevalence survey of primate handlers for evidence of asymptomatic herpes B virus infection. J Infect Dis. 1995;171:1031–1034. doi: 10.1093/infdis/171.4.1031. [DOI] [PubMed] [Google Scholar]
- Glass CM, McLean RG, Katz JB, Maehr DS, Cropp CB, Kirk LJ, McKeirnan AJ, Evermann JF. Isolation of pseudorabies (Aujeszky’s disease) virus from a Florida panther. J Wildl Dis. 1994;30:180–184. doi: 10.7589/0090-3558-30.2.180. [DOI] [PubMed] [Google Scholar]
- Griffiths RA, Boyne JR, Whitehouse A. Herpesvirus saimiri-based gene delivery vectors. Curr Gene Ther. 2006;6:1–15. doi: 10.2174/156652306775515529. [DOI] [PubMed] [Google Scholar]
- Heldstab A, Ruedi D, Sonnabend W, Deinhardt F. Spontaneous generalized Herpesvirus hominis infection of a lowland gorilla (Gorilla gorilla gorilla) J Med Primatol. 1981;10:129–135. doi: 10.1159/000460063. [DOI] [PubMed] [Google Scholar]
- Hennig H, Osterrieder N, Muller-Steinhardt M, Teichert HM, Kirchner H, Wandinger KP. Detection of Marek’s disease virus DNA in chicken but not in human plasma. J Clin Microbiol. 2003;41:2428–2432. doi: 10.1128/JCM.41.6.2428-2432.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hennig H, Wessel K, Sondermeijer P, Kirchner H, Wandinger KP. Lack of evidence for Marek’s disease virus genomic sequences in leukocyte DNA from multiple sclerosis patients in Germany. Neurosci Lett. 1998;250:138–140. doi: 10.1016/s0304-3940(98)00445-5. [DOI] [PubMed] [Google Scholar]
- Holmes GP, Hilliard JK, Klontz KC, Rupert AH, Schindler CM, Parrish E, Griffin DG, Ward GS, Bernstein ND, Bean TW. B virus (Herpesvirus simiae) infection in humans: epidemiologic investigation of a cluster. Ann Intern Med. 1990;112:833–839. doi: 10.7326/0003-4819-112-11-833. [DOI] [PubMed] [Google Scholar]
- Huff JL, Barry PA. B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease. Emerg Infect Dis. 2003;9:246–250. doi: 10.3201/eid0902.020272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Isacson O, Breakefield XO. Benefits and risks of hosting animal cells in the human brain. Nat Med. 1997;3:964–969. doi: 10.1038/nm0997-964. [DOI] [PubMed] [Google Scholar]
- Jainkittivong A, Langlais RP. Herpes B virus infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998a;85:399–403. doi: 10.1016/s1079-2104(98)90064-6. [DOI] [PubMed] [Google Scholar]
- Jainkittivong A, Langlais RP. Herpes B virus infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998b;85:399–403. doi: 10.1016/s1079-2104(98)90064-6. [DOI] [PubMed] [Google Scholar]
- Kalter SS, Heberling RL. Primate viral diseases in perspective. J Med Primatol. 1990;19:519–535. [PubMed] [Google Scholar]
- Keeble SA, Christofinis GJ, Wood W. Natural virus-B infection in rhesus monkeys. J Pathol Bacteriol. 1958;76:189–199. doi: 10.1002/path.1700760121. [DOI] [PubMed] [Google Scholar]
- Kessler MJ, Hilliard JK. Seroprevalence of B virus (Herpesvirus simiae) antibodies in a naturally formed group of rhesus macaques. J Med Primatol. 1990;19:155–160. [PubMed] [Google Scholar]
- Kluge JP, Beran GW, Hill HT, Platt KB. Pseudorabies (Aujetszky’s disease) In: Leman AD, Straw BE, Mengeling WL, D’Allaire S, Taylor DJ, editors. Disease of Swine. Iowa State University Press; Ames: 1992. pp. 312–323. [Google Scholar]
- Laurent S, Esnault E, Dambrine G, Goudeau A, Choudat D, Rasschaert D. Detection of avian oncogenic Marek’s disease herpesvirus DNA in human sera. J Gen Virol. 2001;82:233–240. doi: 10.1099/0022-1317-82-1-233. [DOI] [PubMed] [Google Scholar]
- Lee F, Lin YJ, Deng MC, Lee TY, Huang CC. Prevalence of antibody reaction with cercopithecine herpesvirus 1 antigen in Macaca cyclopis, Macaca fascicularis, and Papio anubis in Taiwan. J Med Primatol. 2007;36:343–347. doi: 10.1111/j.1600-0684.2007.00211.x. [DOI] [PubMed] [Google Scholar]
- Marcaccini A, Lopez PM, Quiroga MI, Bermudez R, Nieto JM, Aleman N. Pseudorabies virus infection in mink: a host-specific pathogenesis. Vet Immunol Immunopathol. 2008;124:264–273. doi: 10.1016/j.vetimm.2008.03.013. [DOI] [PubMed] [Google Scholar]
- Martina BE, Verjans GM, Kuiken T, van AG, Osterhaus AD. In vitro and in vivo replication of seal gammaherpesviruses in cells of multiple species. Microbes Infect. 2007;9:40–46. doi: 10.1016/j.micinf.2006.10.006. [DOI] [PubMed] [Google Scholar]
- Matz-Rensing K, Jentsch KD, Rensing S, Langenhuyzen S, Verschoor E, Niphuis H, Kaup FJ. Fatal Herpes simplex infection in a group of common marmosets (Callithrix jacchus) Vet Pathol. 2003;40:405–411. doi: 10.1354/vp.40-4-405. [DOI] [PubMed] [Google Scholar]
- McClure HM, Keeling ME. Viral diseases noted in the Yerkes Primate Center colony. Lab Anim Sci. 1971;21:1002–1010. [PubMed] [Google Scholar]
- McClure HM, Swenson RB, Kalter SS, Lester TL. Natural genital herpesvirus hominis infection in chimpanzees (Pan troglodytes and Pan paniscus) Lab Anim Sci. 1980;30:895–901. [PubMed] [Google Scholar]
- McStreet GH, Elkunk RB, Latiwonk QI. Investigations of environmental conditions during cluster indicate probable vectors of unknown exogenous agent(s) of multiple sclerosis. Comp Immunol Microbiol Infect Dis. 1992;15:75–77. doi: 10.1016/0147-9571(92)90105-z. [DOI] [PubMed] [Google Scholar]
- Melendez LV, Daniel MD, Hunt RD, Garcia FG. An apparently new herpesvirus from primary kidney cultures of the squirrel monkey (Saimiri sciureus) Lab Anim Care. 1968;18:374–381. [PubMed] [Google Scholar]
- Melendez LV, Espana C, Hunt RD, Daniel MD, Garcia FG. Natural herpes simplex infection in the owl monkey (Aotus trivirgatus) Lab Anim Care. 1969a;19:38–45. [PubMed] [Google Scholar]
- Melendez LV, Hunt RD, Daniel MD, Garcia FG, Fraser CE. Herpesvirus saimiri. II Experimentally induced malignant lymphoma in primates. Lab Anim Care. 1969b;19:378–386. [PubMed] [Google Scholar]
- Mravak S, Bienzle U, Feldmeier H, Hampl H, Habermehl KO. Pseudorabies in man. Lancet. 1987;1:501–502. doi: 10.1016/s0140-6736(87)92105-2. [DOI] [PubMed] [Google Scholar]
- Oya C, Ochiai Y, Taniuchi Y, Takano T, Fujima A, Ueda F, Hondo R, Yoshikawa Y. Prevalence of herpes B virus genome in the trigeminal ganglia of seropositive cynomolgus macaques. Lab Anim. 2008;42:99–103. doi: 10.1258/la.2007.006031. [DOI] [PubMed] [Google Scholar]
- Palmer AE. B virus, Herpesvirus simiae: historical perspective. J Med Primatol. 1987;16:99–130. [PubMed] [Google Scholar]
- Parrish CR, Holmes EC, Morens DM, Park EC, Burke DS, Calisher CH, Laughlin CA, Saif LJ, Daszak P. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol Mol Biol Rev. 2008;72:457–470. doi: 10.1128/MMBR.00004-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramsay E, Stair EL, Castro AE, Marks MI. Fatal Herpesvirus hominis encephalitis in a white-handed gibbon. J Am Vet Med Assoc. 1982;181:1429–1430. [PubMed] [Google Scholar]
- Ritchey JW, Black DH, Rogers KM, Eberle R. In vivo experimentation with simian herpesviruses: assessment of biosafety and molecular contamination. J Am Assoc Lab Anim Sci. 2006;45:7–12. [PubMed] [Google Scholar]
- Rogers KM, Ritchey JW, Payton M, Black DH, Eberle R. Neuropathogenesis of herpesvirus papio 2 in mice parallels infection with Cercopithecine herpesvirus 1 (B virus) in humans. J Gen Virol. 2006;87:267–276. doi: 10.1099/vir.0.81476-0. [DOI] [PubMed] [Google Scholar]
- Santoni F, Lindner I, Caselli E, Goltz M, Di LD, Ehlers B. Molecular interactions between porcine and human gammaherpesviruses: implications for xenografts? Xenotransplantation. 2006;13:308–317. doi: 10.1111/j.1399-3089.2006.00312.x. [DOI] [PubMed] [Google Scholar]
- Sariol CA, Gonzalez-Martinez J, Arana T, Gascot S, Suarez E, Maldonado E, Gerald MS, Rodriguez M, Kraiselburd EN. Differential distribution of antibodies to different viruses in young animals in the free-ranging rhesus macaques of Cayo Santiago. J Med Primatol. 2006;35:369–375. doi: 10.1111/j.1600-0684.2006.00174.x. [DOI] [PubMed] [Google Scholar]
- Schillaci MA, Jones-Engel L, Engel GA, Paramastri Y, Iskandar E, Wilson B, Allan JS, Kyes RC, Watanabe R, Grant R. Prevalence of enzootic simian viruses among urban performance monkeys in Indonesia. Trop Med Int Health. 2005;10:1305–1314. doi: 10.1111/j.1365-3156.2005.01524.x. [DOI] [PubMed] [Google Scholar]
- Schuurman HJ, Pierson RN., III Progress towards clinical xenotransplantation. Front Biosci. 2008;13:204–220. doi: 10.2741/2671. [DOI] [PubMed] [Google Scholar]
- Shah KV, Morrison JA. Comparison of three rhesus groups for antibody patterns to some viruses: absence of active simian virus 40 transmission in the free-ranging rhesus of Cayo Santiago. Am J Epidemiol. 1969;89:308–315. doi: 10.1093/oxfordjournals.aje.a120943. [DOI] [PubMed] [Google Scholar]
- Slifkin M, Doron S, Snydman DR. Viral prophylaxis in organ transplant patients. Drugs. 2004;64:2763–2792. doi: 10.2165/00003495-200464240-00004. [DOI] [PubMed] [Google Scholar]
- Smith PC, Yuill TM, Buchanan RD, Stanton JS, Chaicumpa V. The gibbon (Hylobates lar); a new primate host for Herpesvirus hominia. I A natural epizootic in a laboratory colony. J Infect Dis. 1969;120:292–297. doi: 10.1093/infdis/120.3.292. [DOI] [PubMed] [Google Scholar]
- Trapp S, von EJ, Hofmann H, Kostler J, Wild J, Wagner R, Beer M, Osterrieder N. Potential of equine herpesvirus 1 as a vector for immunization. J Virol. 2005;79:5445–5454. doi: 10.1128/JVI.79.9.5445-5454.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vaha-Koskela MJ, Heikkila JE, Hinkkanen AE. Oncolytic viruses in cancer therapy. Cancer Lett. 2007;254:178–216. doi: 10.1016/j.canlet.2007.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weigler BJ. Biology of B virus in macaque and human hosts: a review. Clin Infect Dis. 1992b;14:555–567. doi: 10.1093/clinids/14.2.555. [DOI] [PubMed] [Google Scholar]
- Weigler BJ. Biology of B virus in macaque and human hosts: a review. Clin Infect Dis. 1992a;14:555–567. doi: 10.1093/clinids/14.2.555. [DOI] [PubMed] [Google Scholar]
- Weigler BJ, Hird DW, Hilliard JK, Lerche NW, Roberts JA, Scott LM. Epidemiology of cercopithecine herpesvirus 1 (B virus) infection and shedding in a large breeding cohort of rhesus macaques. J Infect Dis. 1993a;167:257–263. doi: 10.1093/infdis/167.2.257. [DOI] [PubMed] [Google Scholar]
- Weigler BJ, Hird DW, Hilliard JK, Lerche NW, Roberts JA, Scott LM. Epidemiology of cercopithecine herpesvirus 1 (B virus) infection and shedding in a large breeding cohort of rhesus macaques. J Infect Dis. 1993b;167:257–263. doi: 10.1093/infdis/167.2.257. [DOI] [PubMed] [Google Scholar]
- Weigler BJ, Roberts JA, Hird DW, Lerche NW, Hilliard JK. A cross sectional survey for B virus antibody in a colony of group housed rhesus macaques. Lab Anim Sci. 1990;40:257–261. [PubMed] [Google Scholar]
- Wright J, Falk LA, Collins D, Deinhardt F. Mononuclear cell fraction carrying Herpesvirus saimiri in persistently infected squirrel monkeys. J Natl Cancer Inst. 1976;57:959–962. doi: 10.1093/jnci/57.4.959. [DOI] [PubMed] [Google Scholar]
- Yang L, Maruo S, Takada K. CD21-mediated entry and stable infection by Epstein-Barr virus in canine and rat cells. J Virol. 2000;74:10745–10751. doi: 10.1128/jvi.74.22.10745-10751.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
